Cargando…
Natriuretic peptides and cGMP in metabolic disease
Autor principal: | Collins, Sheila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4565591/ http://dx.doi.org/10.1186/2050-6511-16-S1-A7 |
Ejemplares similares
-
cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015) -
Inhibition of cGMP-metabolizing PDEs as target for cognitive enhancement
por: Rosenbrock, Holger
Publicado: (2015) -
Natriuretic peptides, via GC-A/cGMP, moderate hypoxia-induced VEGF release from astrocytes and thereby pathological neovascularization in the retina
por: Spiranec, Katarina, et al.
Publicado: (2015) -
NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015) -
Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)